Imugene Limited is a biotechnology company developing immunotherapies for cancer treatment, focusing on harnessing the body’s immune system to target and eradicate tumors.
Ticker code: IMU
Sector: Healthcare | Industry: Biotechnology | Website: https://www.imugene.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $102,482,232 | $78,150,904 | 320256978.0 | 74.27 | $76,116,795 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $65,652,679 | $21,935,432 | $10,651,476 | None | None | -17.2 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Partial | 8.7 | $250,420 | $725,730 | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | None |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.320 | 3.2 | None | -3.0 | 18.5 | -41.2 | -75.2 |
IMU Price Chart with Volume and 3EMA
IMU Short Positions
Click HERE to understand why the above moving averages have been chosen.